Half-year report · Q2
2931.TEDINET S100U6LW
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥46.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥348m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥309m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥476m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥267m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥235m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥70.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥59.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.0bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥39.4bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.3bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥18.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥16m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥658m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥361m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥646m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥507m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.8bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.02 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥811m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥251m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥242m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 659
| Item | Context | Value | Unit |
|---|---|---|---|
| Other comprehensive income | Prior1YTDDuration | 29000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -90000000 | JPY |
| Comprehensive income | Prior1YTDDuration | -884000000 | JPY |
| Comprehensive income | CurrentYTDDuration | -325000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -884000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -352000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 0 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 26000000 | JPY |
| Income before income taxes | Prior1YTDDuration | -618000000 | JPY |
| Income before income taxes | CurrentYTDDuration | -476000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 1255000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 1012000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 423000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 604000000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | － | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 1094000000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 59000000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 112000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 5000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | -15000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -25000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -52000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYTDDuration | 88000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -329000000 | JPY |
| Surrender value of insurance ope cf | Prior1YTDDuration | － | JPY |
| Surrender value of insurance ope cf | CurrentYTDDuration | -18000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 19000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 20000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -103000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -239000000 | JPY |
| Increase decrease in provision for retirement benefits and directors retirement benefits ope cf | Prior1YTDDuration | 3000000 | JPY |
| Increase decrease in provision for retirement benefits and directors retirement benefits ope cf | CurrentYTDDuration | -5000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -1000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -2000000 | JPY |
| Subsidy income2 ope cf | Prior1YTDDuration | -303000000 | JPY |
| Subsidy income2 ope cf | CurrentYTDDuration | -48000000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | Prior1YTDDuration | -1000000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | CurrentYTDDuration | -0 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 242000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 233000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | 0 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | 0 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | 37000000 | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | － | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 8000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -28000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 577000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -91000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |